These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30964235)

  • 1. Serum interleukin-17 as a novel biomarker in patients with acne vulgaris.
    Ebrahim AA; Mustafa AI; El-Abd AM
    J Cosmet Dermatol; 2019 Dec; 18(6):1975-1979. PubMed ID: 30964235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum irisin: A prognostic marker for severe acne vulgaris.
    Mustafa AI; El-Shimi OS
    J Cosmet Dermatol; 2018 Oct; 17(5):931-934. PubMed ID: 30238599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity.
    Abd-Elmaged WM; Nada EA; Hassan MH; Elsadek BEM; Abdelrahim EA; Ahmed NS; Toghan R; Ahmed HTI
    J Cosmet Dermatol; 2019 Apr; 18(2):671-676. PubMed ID: 30070012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of serum interleukin-19 in acne vulgaris patients of different clinical severities.
    Saleh HM; Deif MA; El-Husseiny RM
    J Cosmet Dermatol; 2021 Sep; 20(9):3034-3040. PubMed ID: 33538078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of brain-derived neurotrophic factor levels and depressive symptoms in young adults with acne vulgaris.
    He HY; Tian JL; Deng YQ; Xiong X; Xu Y; Liao YM; Fang J; Feng X; Ye X; Li CQ
    BMC Psychiatry; 2019 Jun; 19(1):193. PubMed ID: 31234814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue expression of IL-17A and FOXP3 in acne vulgaris patients.
    Farag AGA; Maraee AH; Rifaat Al-Sharaky D; Elshaib ME; Kohla MSM; Shehata WA
    J Cosmet Dermatol; 2021 Jan; 20(1):330-337. PubMed ID: 32413182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the severity and type of acne lesions with serum zinc levels in patients with acne vulgaris.
    Rostami Mogaddam M; Safavi Ardabili N; Maleki N; Soflaee M
    Biomed Res Int; 2014; 2014():474108. PubMed ID: 25157359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of brain-derived neurotrophic factor in patients with acne vulgaris.
    Mikhael NW; Hamed AM; Mansour AI; Abdelrahman ES
    J Cosmet Dermatol; 2019 Dec; 18(6):1998-2003. PubMed ID: 30980616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin in the pilosebaceous unit: alteration of ghrelin in patients with acne vulgaris.
    Cicek D; Demir B; Erder I; Kuloglu T; Ucer O; Aydin S; Ucak H; Dertlioglu S; Kalayci M
    Eur J Dermatol; 2015; 25(4):323-8. PubMed ID: 26629576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma dermcidin levels in acne patients, and the effect of isotretinoin treatment on dermcidin levels.
    Alatas ET; Kara Polat A; Kalayci M; Dogan G; Akin Belli A
    Dermatol Ther; 2019 Sep; 32(5):e13044. PubMed ID: 31364786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor α-308 G/A and interleukin 1 β-511 C/T gene polymorphisms in patients with scarring acne.
    Akoglu G; Tan C; Ayvaz DC; Tezcan I
    J Cosmet Dermatol; 2019 Feb; 18(1):395-400. PubMed ID: 29675912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL40: A novel potential link between inflammation and dyslipidemia in acne vulgaris.
    Ebrahim A; Mustafa AI; El-Shimi OS; Fathy MA
    J Cosmet Dermatol; 2020 May; 19(5):1219-1223. PubMed ID: 31490625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet.
    Agamia NF; Abdallah DM; Sorour O; Mourad B; Younan DN
    Br J Dermatol; 2016 Jun; 174(6):1299-307. PubMed ID: 26799159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In severe acne vulgaris, TNF-α gene variants are connected to increased TNF-α gene expression and insulin resistance.
    AbdElneam AI; Alhajlah S; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
    Skin Res Technol; 2024 Jul; 30(7):e13811. PubMed ID: 38923681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum desnutrin levels in patients with acne vulgaris.
    Demir B; Ucak H; Cicek D; Aydin S; Erden I; Dertlioglu SB
    Eur J Dermatol; 2014; 24(5):589-93. PubMed ID: 25152512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum TWEAK in acne vulgaris: An unknown soldier.
    El-Taweel AEI; Salem RM; Abdelrahman AMN; Mohamed BAE
    J Cosmet Dermatol; 2020 Feb; 19(2):514-518. PubMed ID: 31135089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated survivin levels in patients with acne vulgaris.
    Aksoy Saraç G; Kader S; Akdağ T
    J Cosmet Dermatol; 2022 Apr; 21(4):1744-1748. PubMed ID: 35037363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of interleukin-1 beta expression in acne vulgaris and acne scars.
    ElAttar Y; Mourad B; Alngomy HA; Shams El Deen A; Ismail M
    J Cosmet Dermatol; 2022 Oct; 21(10):4864-4870. PubMed ID: 35174608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin19 gene polymorphism and its serum level in acne vulgaris patients.
    Bazid H; Marae A; Tayel N; Sleem R; Mahrous E; Mostafa MI; El Gayed EMA
    J Immunoassay Immunochem; 2022 Jan; 43(1):1951291. PubMed ID: 34292139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris.
    Abulnaja KO
    Braz J Med Biol Res; 2009 Jun; 42(6):501-5. PubMed ID: 19448897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.